A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Alopecia areata (AA) is a disease that happens when the immune system attacks hair
follicles and causes hair loss. AA usually affects the head and face, but hair loss can
happen on any part of the body. The purpose of this study is to assess how safe,
effective, and ...
Age: 12 - 63 years
Gender: All
Regeneron AA Multicenter (Dupilumab)
This is a prospective, randomized, double blind, placebo-controlled clinical trial. The
study will take place at 4 sites. This trial will enroll a total of 68 patients with
moderate to severe AA (affecting more than 50% of the scalp) at the time of screening
with a t...
Age: 18 years - 66+
Gender: All
PF-06651600 for the Treatment of Alopecia Areata
This is a global Phase 2b/3 study to evaluate the safety and effectiveness of an
investigational study drug (called PF-06651600) in adults and adolescents (12 years and
older) who have 50% or greater scalp hair loss. The study is placebo-controlled, meaning that
some...
Age: 12 years - 66+
Gender: All